University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Progression and Etiology of Cortical Porosity in Diabetic Bone Disease

Completed

Conditions: Type 2 Diabetes

Interventions: Device: XtremeCT

First Posted Date: 2019-12-23

Last Posted Date: 2023-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 96

Registration Number: NCT04208230

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Quality Improvement Project for Reproductive Health Services in India, Phase 1

Not Applicable

Completed

Conditions: Delivery
Reproductive Health
Maternal Health

Interventions: Behavioral: QI Collaborative

First Posted Date: 2019-12-23

Last Posted Date: 2019-12-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 2989

Registration Number: NCT04208867

Locations: 🇮🇳
Population Services International, Lucknow, Uttar Pradesh, India

Quality Improvement Project for Maternal Health and Family Planning Services in Kenya

Not Applicable

Completed

Conditions: Delivery
Maternal Health
Family Planning

Interventions: Behavioral: Quality Improvement Collaborative

First Posted Date: 2019-12-23

Last Posted Date: 2019-12-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 3354

Registration Number: NCT04208191

Locations: 🇰🇪
Innovations for Poverty Action, Nairobi, Kenya

Improving Person Centered Care for Post Abortion Patients in Kenya

Not Applicable

Completed

Conditions: Reproductive Health

Interventions: Behavioral: Person Centered Care - Post Abortion Support

First Posted Date: 2019-12-20

Last Posted Date: 2020-01-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 371

Registration Number: NCT04206514

Locations: 🇰🇪
Marie Stopes International Kenya, Nairobi, Kenya

Improving Person-Centered Care for Family Planning in India

Not Applicable

Completed

Conditions: Family Planning

Interventions: Behavioral: Training of AHSAs on PCC for FP
Behavioral: Enhanced FP training

First Posted Date: 2019-12-20

Last Posted Date: 2019-12-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1104

Registration Number: NCT04206527

Locations: 🇮🇳
Population Services International, Lucknow, Uttar Pradesh, India

A Neuroimaging Study of Open-label Placebo in Depressed Adolescents

Not Applicable

Recruiting

Conditions: Depression

Interventions: Behavioral: Open Label Placebo with Rationale
Behavioral: Open Label Placebo without Rationale

First Posted Date: 2019-12-17

Last Posted Date: 2024-12-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT04201106

Locations: 🇺🇸
UCSF, San Francisco, California, United States

Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions

Phase 2

Recruiting

Conditions: Infusion Reaction
Monoclonal Antibody

Interventions: Drug: Montelukast 10 Mg Oral Tablet

First Posted Date: 2019-12-13

Last Posted Date: 2023-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80

Registration Number: NCT04198623

Locations: 🇺🇸
Community Cancer Institute, Clovis, California, United States

Right Ventricular Pacing in Pulmonary Arterial Hypertension

Not Applicable

Conditions: Pulmonary Artery Hypertension
Right Ventricular Dysfunction

Interventions: Procedure: Temporary right ventricular pacing

First Posted Date: 2019-12-11

Last Posted Date: 2021-05-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 16

Registration Number: NCT04194632

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Thermocoagulation for Treatment of Precancerous Cervical Lesions

Not Applicable

Completed

Conditions: CIN 2/3
Human Immunodeficiency Virus
HPV Infection

Interventions: Device: Thermocoagulation

First Posted Date: 2019-12-10

Last Posted Date: 2023-01-25

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 379

Registration Number: NCT04191967

Locations: 🇰🇪
Kenya Medical Research Institute, Kisumu, Kenya

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Phase 2

Terminated

Conditions: Anatomic Stage IV Breast Cancer AJCC v8
Prognostic Stage IV Breast Cancer AJCC v8

Interventions: Biological: Pembrolizumab
Drug: Tamoxifen
Drug: Vorinostat

First Posted Date: 2019-12-09

Last Posted Date: 2023-08-31

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1

Registration Number: NCT04190056

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy